THERAVANCE BIOPHARMA INC

Ticker: TBPH CUSIP: G8807B106 Class: Common Stock

OXFORD ASSET MANAGEMENT LLP's Holding History (CIK: 0001438284)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025

Shares 14,429 Value ($000) $159 Avg Close $9.72 Range $7.90 - $11.82

Q4 2019

Shares 13,961 Value ($000) $361 Avg Close $19.43 Range $15.72 - $26.47

Q3 2019

Shares 15,109 Value ($000) $294 Avg Close $20.20 Range $16.00 - $24.34

Q4 2014

Shares 172,016 Value ($000) $2,617 Avg Close $17.42 Range $13.11 - $24.06

Q3 2014

Shares 324,337 Value ($000) $7,593 Avg Close $29.01 Range $23.01 - $34.07

Q2 2014

Shares 247,312 Value ($000) $8,458 Avg Close $27.05 Range $14.75 - $35.67

Period	Shares	Value ($000)	Average Close	Price Range
Q2 2025	14,429	$159	$9.72	$7.90 - $11.82
Q4 2019	13,961	$361	$19.43	$15.72 - $26.47
Q3 2019	15,109	$294	$20.20	$16.00 - $24.34
Q4 2014	172,016	$2,617	$17.42	$13.11 - $24.06
Q3 2014	324,337	$7,593	$29.01	$23.01 - $34.07
Q2 2014	247,312	$8,458	$27.05	$14.75 - $35.67